triazoles has been researched along with Psoriasis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besuyen, R; Coates, LC; Gao, J; Gossec, L; Hendrikx, T; Leung, YY; Meuleners, L; Ogdie, A; Orbai, AM; Tasset, C; Tillett, W; Trivedi, M | 1 |
| Bonovas, S; Danese, S; Lasa, JS; Olivera, PA; Peyrin-Biroulet, L | 1 |
| Georgiou, S; Plachouri, KM | 1 |
| Berger, S; Bertin, J; Krueger, JG; Maari, C; Papp, K; Peter Tak, P; Scott, N; Simeoni, M; Tompson, D; Wang, S; Weisel, K | 1 |
| Aletaha, D; Baraliakos, X; Boehncke, WH; de Wit, M; Dörner, T; Dougados, M; Emery, P; Fleischmann, RM; Geissler, K; Isaacs, JD; Kerschbaumer, A; Kremer, J; Lee, EB; Maksymowych, WP; McInnes, I; Nash, P; Pope, JE; Smolen, JS; Stoffer-Marx, M; Takeuchi, T; Tam, LS; Tanaka, Y; Trauner, M; van den Bosch, F; van der Heijde, D; Voshaar, M; Westhovens, R; Winthrop, KL; Xavier, R | 1 |
| Adas, M; Bechman, K; Cope, AP; Galloway, JB; Mootoo, A; Norton, S; Patel, V; Qureshi, S; Rampes, S; Yates, M | 1 |
| Iwatsuki, K; Katayama, N; Morizane, S; Motoki, T; Omori, M; Sugimoto, S | 1 |
| Ahmad, SF; Al-Harbi, MM; Al-Harbi, NO; Al-Hosaini, KA; Al-Sharary, SD; Ansari, MA; Attia, SM; El-Sherbeeny, AM; Nadeem, A; Siddiqui, N; Zoheir, KM | 1 |
| Binks, MH; Griffiths, CE; Hanrott, KE; Hicks, KJ; Ludbrook, VJ; Patel, JS; Reich, K; Schifano, LA; Simeoni, M; Watson, J; Wilson, P; Wyres, MR | 1 |
| Geria, AN; Scheinfeld, NS | 1 |
| Hashimoto, K; Kumagai, C; Nishioka, T; Shinohara, M; Tanimoto, N | 1 |
| Caminal-Montero, L; Coto-Segura, P; Esteve-Martinez, A; Mas-Vidal, A; Santos-Juanes, J | 1 |
| Bovenschen, HJ; Langewouters, AM; Otero, ME; Seyger, MM; van de Kerkhof, PC; van Rens, DW; van Vlijmen-Willems, IM | 1 |
| Bovenschen, HJ; Mertens, J; Steijlen, PM; Thissen, CA; van de Kerkhof, PC; Verfaille, CJ | 1 |
| Heremans, A; Lucker, GP; Steijlen, PM; van de Kerkhof, PC; van Pelt, H | 1 |
5 review(s) available for triazoles and Psoriasis
| Article | Year |
|---|---|
Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
Topics: Arthritis, Rheumatoid; Azetidines; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Incidence; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Janus Kinases; Piperidines; Placebos; Psoriasis; Purines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Spondylitis, Ankylosing; Sulfonamides; Survival Analysis; Treatment Outcome; Triazoles | 2020 |
JAK inhibitors in chronic plaque psoriasis: What is known so far.
Topics: Adamantane; Azetidines; Humans; Janus Kinase Inhibitors; Janus Kinases; Niacinamide; Nitriles; Piperidines; Prospective Studies; Psoriasis; Purines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sulfonamides; Triazoles | 2020 |
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Topics: Adamantane; Advisory Committees; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Azetidines; Cytokines; Drug Therapy, Combination; Europe; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Niacinamide; Piperidines; Psoriasis; Purines; Pyrazoles; Pyridines; Pyrimidines; Rheumatology; Spondylarthropathies; Spondylitis, Ankylosing; Sulfonamides; Triazoles | 2021 |
Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Azetidines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Heterocyclic Compounds, 3-Ring; Humans; Inflammatory Bowel Diseases; Janus Kinase Inhibitors; Piperidines; Psoriasis; Pulmonary Embolism; Purines; Pyrazoles; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Risk; Spondylarthropathies; Spondylitis, Ankylosing; Sulfonamides; Triazoles; Venous Thromboembolism; Venous Thrombosis | 2021 |
Talarozole, a selective inhibitor of P450-mediated all-trans retinoic acid for the treatment of psoriasis and acne.
Topics: Acne Vulgaris; Animals; Benzothiazoles; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Psoriasis; Structure-Activity Relationship; Tretinoin; Triazoles | 2008 |
6 trial(s) available for triazoles and Psoriasis
| Article | Year |
|---|---|
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR).
Topics: Adaptation, Psychological; Arthritis, Psoriatic; Double-Blind Method; Fatigue; Humans; Janus Kinase Inhibitors; Least-Squares Analysis; Minimal Clinically Important Difference; Pain; Physical Functional Performance; Psoriasis; Pyridines; Quality of Life; Sleep Wake Disorders; Social Behavior; Treatment Outcome; Triazoles | 2020 |
Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled Study.
Topics: Adult; Canada; CD3 Complex; Dermis; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxazepines; Protein Kinase Inhibitors; Psoriasis; Receptor-Interacting Protein Serine-Threonine Kinases; Remission Induction; Signal Transduction; T-Lymphocytes; Time Factors; Treatment Outcome; Triazoles | 2020 |
Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.
Topics: Adolescent; Adult; Aged; Azetidines; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Gene Expression; Humans; Janus Kinase 1; Male; Middle Aged; Psoriasis; Quality of Life; Treatment Outcome; Triazoles; Young Adult | 2016 |
Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study.
Topics: Administration, Oral; Adult; Benzothiazoles; Cell Proliferation; Dermatologic Agents; Female; Humans; Immunohistochemistry; Keratolytic Agents; Male; Middle Aged; Psoriasis; Tretinoin; Triazoles | 2007 |
Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
Topics: Administration, Oral; Adult; Aged; Benzothiazoles; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psoriasis; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Triazoles | 2007 |
Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis.
Topics: Administration, Topical; Adult; Chronic Disease; Double-Blind Method; Female; Humans; Lipoxygenase Inhibitors; Male; Middle Aged; Piperazines; Prospective Studies; Psoriasis; Triazoles | 1996 |
4 other study(ies) available for triazoles and Psoriasis
| Article | Year |
|---|---|
A Case of Psoriasis Complicated by Breast Cancer after Systemic Treatments Including Biologics.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biological Products; Breast Neoplasms; Female; Humans; Immunosuppressive Agents; Nitriles; Psoriasis; Triazoles | 2018 |
Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Topics: Aminoquinolines; Animals; Azepines; Disease Models, Animal; Imiquimod; Inflammation; Interleukin-17; Interleukin-22; Interleukins; Male; Mice; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; Psoriasis; Signal Transduction; Skin; Triazoles | 2015 |
Sitagliptin, a dipeptidyl peptidase-IV inhibitor, improves psoriasis.
Topics: Adult; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hypoglycemic Agents; Psoriasis; Pyrazines; Sitagliptin Phosphate; T-Lymphocytes; Treatment Outcome; Triazoles | 2012 |
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Eruptions; Extremities; Female; Humans; Middle Aged; Psoriasis; Pyrazines; Sitagliptin Phosphate; Torso; Triazoles | 2012 |